Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS)

CNY 23.79

(-0.08%)

Market Cap (In CNY)

4.74 Billion

Revenue (In CNY)

860.93 Million

Net Income (In CNY)

219.08 Million

Avg. Volume

820.28 Thousand

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
17.49-32.41
PE
-
EPS
-
Beta Value
0.425
ISIN
CNE100004041
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Zhongyi Geng
Employee Count
-
Website
https://www.jibeier.com.cn
Ipo Date
2020-05-18
Details
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research, development, production, and sale of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products cover various therapeutic areas, such as improving white blood cells, enhancing immunity, treating joint diseases, anti-hypertension, anti-eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach diseases, and other diseases. The company was founded in 2001 and is based in Zhenjiang, China.